文献速递骨质疏松与钙磷/甲状旁腺

妊娠期维生素D补充对母婴结局的随机试验

Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial.
PubMed 文献 · J Clin Endocrinol Metab · 2026-07-16

高剂量组母婴达到25(OH)D≥20 ng/mL的比例显著更高,但新生儿骨矿物质含量无显著差异,未发现安全性问题。

要点

  • 高剂量维生素D补充使100%孕妇和77%新生儿达到25(OH)D≥20 ng/mL。
  • 低剂量组分别为85%和40%,组间差异显著(P=.001)。
  • 新生儿骨矿物质含量两组无显著差异(P=.059)。

核心结论

  • 较高剂量维生素D补充可安全实现母婴生化充足,但对新生儿骨结局无显著影响。

主要发现

  • 高剂量组孕妇100%和新生儿77%达到25(OH)D≥20 ng/mL,低剂量组分别为85%和40%(P=.001)。
  • 母婴分娩时平均25(OH)D水平组间趋势相似(P=.001)。
  • 新生儿全身骨矿物质含量两组无显著差异(45.9±8.5 vs 42.2±7.1 g,P=.059),骨密度和骨面积也无差异。
  • 未发现与补充相关的安全性问题。

关键数值与推荐

  • 主要结局为分娩时25(OH)D≥20 ng/mL的比例和新生儿约1月龄时骨矿物质含量。

临床怎么用

  • 对于基线维生素D不足的孕妇,较高剂量补充可更有效达到生化充足,但未显示改善新生儿骨结局。

局限性

  • 仅67名新生儿有可评估的DXA扫描,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Hypovitaminosis D during pregnancy is common and may have adverse maternal and neonatal effects. While randomized trials show that supplementation improves biochemical vitamin D status, the optimal dose and its effects on neonatal bone outcomes remain uncertain. OBJECTIVE: To compare the effects of 2 vitamin D supplementation doses during pregnancy on maternal and neonatal serum 25-hydroxyvitamin D (25(OH)D) at delivery, and on neonatal bone mineral content. METHODS: In this double-blind trial, pregnant women ≤17.5 weeks' gestation with baseline 25(OH)D 10 to 30 ng/mL were randomized to receive either 20 000 IU/week or 10 000 IU every 2 weeks (equivalent to 714 IU/day) vitamin D3. Primary outcomes were the proportion of women achieving a 25(OH)D level ≥20 ng/mL at delivery and neonatal bone mineral content (BMC) at ∼1 month of age. We used liquid chromatography tandem mass spectrometry (standard LC-MS/MS) at a CDC-certified laboratory. RESULTS: One hundred and ninety-two maternal neonatal pairs had complete biochemical data and 67 neonates had evaluable DXA scans. A significantly higher proportion (100%) of women and neonates (77%) in the higher dose group achieved 25(OH)D levels ≥20 ng/mL at delivery, compared with the lower dose group (85% and 40%, respectively, P = .001). Mean 25(OH)D in mothers and neonates at delivery followed a similar pattern (P = .001). However, neonatal subtotal whole-body BMC did not differ between groups (45.9 ± 8.5 vs 42.2 ± 7.1 g, respectively; P = .059), nor did neonatal bone mineral density or bone area. We did not identify any safety concerns related to supplementation. CONCLUSION: Higher dose vitamin D supplementation safely achieved biochemical sufficiency in mothers and neonates without measurable effect on neonatal bone outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Chakhtoura M, Nassar AH, Ajjour S, et al. Maternal and neonatal outcomes of vitamin D supplementation in hypovitaminosis D pregnancy: preg-D randomized trial. J Clin Endocrinol Metab. 2026. PMID: 42461330. doi:10.1210/clinem/dgag245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。